BRO - Brown & Brown, Inc. Pick

Research brief

Oct 28, 2026 Morning

01:00 PM UTC

Brown & Brown, Inc. BRO low

BRO

Conf. Low

Pick Pr. $66.53

Stop Pr. $65.75

Curr. Pr. $65.88

Change -0.98%

Rem. Days 7

Summary

BUY NOW: BRO — Brown & Brown; Speculative, Low confidence. The repaired decision is an immediate seven-calendar-day recovery trade, not a pending-limit-order idea. The original research entry is $66.46499634 at October 28, 2026, 11:03 EDT; the publication observation is $66.44499969 at 11:13 EDT. These are research observations, not executed fills. finance.yahoo
Decider estimate: net expected policy return is +0.3176% before forecast uncertainty, versus estimated SPY −0.0268% over the matched interval. Estimated excess is +0.3444 percentage points; after the decider's 1.30-point uncertainty deduction, it is −0.9556 points. This is a fragile positive absolute-return forecast, not demonstrated alpha.
The operating news is a contradiction, not a bullish surprise: October 26 results reported 1.2% organic growth and adjusted EBITDAC margin of 34.6%, down from 36.6%. The recovery thesis must work despite those figures. brownandbrown
Risk assumptions: authored stop $65.75, conditional delayed/gap stop-exit estimate $64.80, seven-day T1 $70.50, and actual full-position profit barrier $73.7280 at the research entry. Only 9% of the decider's scenarios exit at that actual profit barrier; these assumptions are not historical frequencies or guaranteed fills.
Publication calculations leave BRO ahead of ZTS and ADSK under the unchanged economic scenarios. Membership is supported by a freshly fetched official tracking-fund holdings file dated October 27, rather than a direct S&P constituent file; that provenance limitation remains explicit. ssga

Why Now

Released information, not an anticipated earnings beat

Brown & Brown first disclosed third-quarter results on October 26; the October 27, 08:00 EDT conference call followed that disclosure. Revenue was $1.725 billion, up 7.4%, but adjusted EPS increased only 1.9% to $1.07 and GAAP diluted EPS declined 1.5% to $0.67. Acquired revenue is excluded from the organic-growth reconciliation, so headline revenue growth should not be mistaken for organic acceleration. brownandbrowninvestor.bbro

The completed October 27 session fell 4.97%, on approximately 2.32 times the prior 19-session average volume in the retained calculation. Conversely, September 30–October 27 performance was +10.92%, versus XLF +4.64% and SPY +0.92%. Those observations show both prior relative strength and a forceful rejection of the earnings outlook—not uncomplicated momentum. finance.yahoo

Decider inference: the current edge is limited support-area mean reversion after adverse released earnings. It is not a new guidance raise, an Accession announcement, or quantified seven-day revenue from the October 22 COMPASS announcement. The issuer lists COMPASS, but the supplied evidence supplies no incremental short-horizon monetization estimate. investor.bbro

The repaired selection changed because a lower BRO entry improved the unchanged scenario economics. It did not assume better earnings, raise the 9/38/53 policy-exit odds, or replace the conditional economic terminal value of $66.949091217 with an increasingly optimistic percentage forecast. The decider's original synchronized research freeze remains the frontmatter reference; later prices are separately identified below.

Entry acceptance is imperfect

At the publication check, the latest completed five-minute bar ended October 28 at 11:10 EDT, with a $66.255 low/close and regular-phase VWAP $66.7641. The 11:13 quote of $66.44499969 remained below that VWAP but above the previously identified $66.15 October 15 low. No VWAP reclaim is claimed. Phase VWAP resets with the trading phase and is not event-anchored VWAP. finance.yahoo

Decider analysis: $66.82 is the frozen first-resistance diagnostic, followed by the observed $66.89 rebound high and $67.70 supply area. The nearest obstacle must not replace the seven-day $70.50 T1. Reaching the actual profit barrier requires substantially more travel than simply clearing resistance. The model assigns only 9% to that full policy exit, while its conditional time outcome assumes much less than a return to pre-earnings prices.

The prior $67.10 event-session low has already been breached; an unbroken hold of that level is not part of this thesis. The retained pre-event ATR14 is about $2.063571. The publication completed-bar low remains less than 2.5 such ATRs below the $71.08 pre-print close, and the original event also did not meet the mandatory shock thresholds. The provider's beta is 0.593. The decider therefore treats poor acceptance as a material risk penalty, not an invented mandatory-reclaim veto. finance.yahoo

Business And Market Context

Business quality supports survivability, not a seven-day price floor

Brown & Brown distributes insurance and related services through retail and specialty distribution operations, including property/casualty, employee benefits, wholesale brokerage and specialty programs. The business is an insurance intermediary; the investment case here is not a direct bet on underwriting gains. finance.yahoo

The October 26 release describes a challenging rate environment and the contribution of Accession, added just over a year earlier. Adjusted EPS adds back acquisition-related items and amortization; it is not interchangeable with GAAP EPS. The decider views integration costs, slowing organic growth and margin compression as the principal operating challenges, rather than assuming acquisition-led scale alone produces an immediate rerating. brownandbrown

As of September 30, reported corporate cash excluding fiduciary funds was $1.099 billion, current debt $413 million and total debt $7.759 billion. Nine-month operating cash flow was $1.140 billion, with $77 million of capital expenditures. Fiduciary cash of $2.442 billion is not corporate debt-service capacity. The retained calculation derives approximately $6.660 billion of net debt and 4.2 times quarterly pretax-income-plus-interest coverage; these are analytical proxies, not covenant tests. brownandbrown

Inference: those figures support a survivable balance sheet, not immunity to a further selloff. Normal trading turnover is adequate in the retained data, but executable order-book depth and stressed-market liquidity were not independently audited. finance.yahoo

Market and matched benchmark

SPY's October 27 close of $769.66 was below its completed-session SMA20 of $770.4115, but above SMA50 $766.6953 and SMA200 $724.8132. The separate live publication quote was $770.89990234 at October 28, 11:13 EDT. Completed trend observations and a live quote are not interchangeable. finance.yahoo

The inherited market work found stronger equal-weight/defensive participation alongside weaker growth-stock leadership, with inflation and rates limiting confidence in recovery. Its checked calendar includes the October 28 FOMC, October 29 GDP/PCE, November 3 election and November 4 ISM services release at 10:00 ET. These broad macro exposures affect scenarios and confidence; they are not pending company-specific binary-event exclusions. finance.yahoofinance.yahoobls.govhome.treasuryssgaismworld.org

Decider benchmark estimate: from the synchronized $770.70001221 SPY research quote at 11:03 EDT, retain 25%/45%/30% weights on approximately $783.9964/$773.1933/$757.7603 terminal values, less 0.10 percentage point friction. This yields −0.02679865% expected net seven-day SPY buy-and-hold return. The model assumes no dividend entitlement for a new SPY buyer and treats fund expense accrual as embedded. These are uncalibrated scenario assumptions, not source-issued targets or trailing returns.

Membership and portfolio fit

The fresh official State Street workbook, dated October 27, 2026, includes BRO and all five displayed alternatives. A normalized-symbol comparison found all 503 retained equity symbols in that workbook. The S&P page independently fetched October 28 did not expose a dated full constituent table. Accordingly, current membership is corroborated through the official tracking-fund holdings and retained continuity evidence, not certified from a newly obtained direct S&P list. ssga spglobal

Supplied portfolio context, not a new market observation: active public positions are DELL, IQV, NDAQ, NEE and UPS; BRO is not a duplicate. One new position uses one of twelve slots, approximately 8.33% of fund value. Financial Services already represents 8.47%, including NDAQ, while cash is 58.15%. On a static-weight calculation, one BRO slot would take financial exposure to roughly 16.80%. This is a concentration cost, not a reason to reject an otherwise supported candidate. Recent closed-position correlations were not supplied.

Factor Stack

Factor	Source-reported observation or evidence limitation	Decider interpretation
Catalyst/news	October 26 results: organic growth 1.2%; adjusted EBITDAC margin 34.6% versus 36.6%. brownandbrown	A speculative recovery despite weak news, not a beat-and-raise trade.
Growth/profitability	Revenue +7.4%; adjusted EPS +1.9%; GAAP EPS −1.5%; positive nine-month operating cash flow. brownandbrown	Cash generation helps resilience, while acquisition effects and margin erosion limit conviction.
Valuation	Provider trailing P/E about 21.03 and forward P/E 13.87 at the publication fetch; the forward estimate's revision date is unavailable. finance.yahoo	Valuation context, not a seven-day fair-value target or evidence of upward revisions.
Momentum/relative strength	September 30–October 27: BRO +10.92%, XLF +4.64%, SPY +0.92%; October 27 −4.97%. Publication price is below regular-phase VWAP. finance.yahoo	Prior leadership is offset by current distribution and weak acceptance.
Sentiment/social	Retained targeted checks did not establish a verified, comparable BRO conviction panel or measured attention trend. reddit	No positive social-confirmation credit; absence is not a veto or a probability calibration.
Estimates/revisions	No dated consensus-revision series or fitted seven-day exit reference class was established in the supplied research.	No claim of analyst-upgrade momentum; all exit odds and time means remain explicit decider judgments.

Investment Thesis

A modest recovery can create a small positive mean

Decider thesis: positive cash generation, earlier relative strength and the observable $66.15 support area provide a limited basis for partial mean reversion. The strongest contradiction is weak organic growth plus heavy post-results selling. That contradiction is already reflected in low profit-barrier odds, a substantial stop branch, conservative terminal recovery and adverse stress—not hidden behind the attractive distance to T1.

The following are the decider's frozen assumptions and calculations at the 11:03 research entry, not company guidance:

Input or calculated diagnostic	Research freeze
Entry / authored stop	$66.46499634 / $65.75
Conditional expected actual stop exit, before friction	$64.80
Authored-stop distance / modeled stop-branch return	1.075749% / −2.505072%
First resistance / significant supply	$66.82 / $67.70
Seven-day T1 / T1 return	$70.50 / +6.070870%
Actual full-position profit barrier / return	$73.72800293 / +10.927566%
Profit-barrier exit / stop exit / time exit	9% / 38% / 53%
Conditional time-exit total return	+0.728345604%
Total estimated friction	0.10 percentage point
Expected net policy return / matched SPY	+0.317577% / −0.026799%
Expected excess / mean uncertainty / adjusted excess	+0.344375 / 1.30 / −0.955625 percentage points

The actual profit barrier is entry + 1.8 × (T1 − entry). It is neither T1 itself nor 1.8 times T1's price. T1 is a strategy-horizon reference at prior supply; crossing $66.82 or touching $70.50 does not establish the modeled profit exit. The decider's illustrative 36% chance of clearing $67.70 multiplied by 25% subsequent barrier-exit chance explains the retained 9%; multiplying subjective estimates does not create empirical calibration.

Arithmetic: 0.09 × 10.927566376 + 0.38 × (−2.505072489) + 0.53 × 0.728345604 − 0.10 = +0.317576598%. The pre-uncertainty absolute-return gate passes. The T1-to-authored-stop distance ratio is approximately 5.64, but this favorable-looking geometry is not an independent eligibility rule and does not overcome weak forecast support by itself.

Dividend treatment is explicit and not decisive

The October 21 issuer declaration increased the quarterly dividend to $0.18, with November 4 record date and November 11 payment date. Retained secondary ex-date evidence supports November 4 entitlement, but exact early-exit entitlement and exchange designation remain unresolved. investor.bbrmoomoofinra.org

Decider convention: the conditional quoted time terminal is post-ex $66.769091217, plus $0.18 cash once, for economic terminal value $66.949091217. This is a dividend receivable, not cash paid within the seven-day research interval. No earlier-exit dividend is assumed in the conservative mean. Omitting every BRO dividend still gives estimated net return +0.174042% at the research entry, and BRO still leads dividend-maximal ZTS by 0.272201 percentage point on adjusted excess. The unresolved entitlement detail therefore does not determine the selected symbol.

Opportunity cost and uncertainty

The decider's full comparison covered eight modeled scenarios, two mandatory-trigger watchlists and eight discovery reserves. The reserves were not falsely classified as fully underwritten return failures. The five supplied viable rejected-finalist packets are preserved in frontmatter; no replacement research or additional discovery is introduced here.

Decider calculations at the authoritative research freeze:

Rank	Candidate	Net mean	Excess vs SPY	Mean uncertainty	Adjusted excess	Why not selected
1	BRO	+0.3176%	+0.3444 pp	1.30 pp	−0.9556 pp	Selected; modest terminal recovery and smaller assigned model uncertainty.
2	ZTS	+0.5510%	+0.5778 pp	2.20 pp	−1.6222 pp	Larger raw mean, but competitive/guidance and issuer-model uncertainty reduce rank.
3	ADSK	+0.9746%	+1.0014 pp	3.00 pp	−1.9986 pp	Larger raw mean, but growth-tape, failed-breakout and delayed-stop exposure carry more uncertainty.
4–6	PODD, STZ, EIX	Nonpositive	Diagnostic only	2.50 / 2.30 / 2.30 pp	Below passing names	Failed the positive absolute-return gate in their authored scenarios; not invented hard rejections.

The operating and price evidence underlying these different estimates includes ZTS's guidance/companion-animal weakness, ADSK's failed breakout, and the retained PODD/STZ/EIX operating and event risks. Those observations support the decider's comparative judgments, not the numerical probabilities themselves. investor.zoeinvestors.auinvestors.inir.cbrandssec.gov

BRO's advantage is subjective and fragile, not interval-dominant or statistically demonstrated alpha. Screen rank 13 versus ZTS rank 3 does not override a materially different adjusted-excess ranking. Confidence is descriptive, not a numerical probability, gate or ranking deduction.

Symmetric adverse stress

Decider stress estimates jointly weaken the market and stock forecasts rather than pairing adverse stocks with an arbitrarily favorable SPY. SPY becomes −1.073087%; BRO profit/stop/time odds become 6/43/51, expected actual stop exit $64.30, friction 0.15 point and conditional terminal value $66.61424121. Entry, authored stop, T1, horizon and execution policy remain fixed.

Candidate	Base net / excess	Adverse net / excess	Declared uncertainty / stress minimum	Declared uncertainty covers stress?
BRO	+0.3176% / +0.3444 pp	−0.7805% / +0.2926 pp	1.3000 / 1.0981 pp	Yes
ZTS	+0.5510% / +0.5778 pp	−1.5304% / −0.4573 pp	2.2000 / 2.0814 pp	Yes
ADSK	+0.9746% / +1.0014 pp	−1.5877% / −0.5146 pp	3.0000 / 2.5623 pp	Yes

The supporting challenge is weak organic/margin performance and post-earnings selling in BRO, ZTS's guidance weakness and ADSK's breakout/growth-tape exposure, alongside macro risk. The numeric overrides are the decider's assumptions, not source-reported forecasts. brownandbrowninvestor.zoeinvestors.aubls.gov

BRO's profit-to-stop and profit-to-time probability-shift headroom is only 2.36439 and 3.113963 percentage points, respectively; ZTS's is 4.773108/10.150913 and ADSK's 6.140922/11.554478. These are calculator sensitivities, not calibrated odds. Mean uncertainty covers the coherent stress once; it is not added again to the stress loss, and ATR/beta are not automatically translated into deductions. Negative adjusted excess and negative stress returns remain disclosures, not extra vetoes on a supported positive base net return.

Publication quote and support check

The separately fetched observations below are dated October 28, 2026. All seven quote requests, including SPY, succeeded on the first attempt; no retry or stale-quote fallback was used. Prices are not guaranteed executable fills.

Symbol	Publication price	Quote time, EDT	Minimum low in returned completed 5-minute bars	Last completed bar ends
BRO	$66.44499969	11:13	$66.255	11:10
ZTS	$77.87000275	11:12	$78.00	11:10
ADSK	$242.07000732	11:13	$241.855	11:10
PODD	$148.02499390	11:12	$148.06	11:10
STZ	$130.44000244	11:13	$130.0101	11:10
EIX	$58.73500061	11:13	$58.055	11:10

Sources for each respective observation: BRO finance.yahoo; ZTS finance.yaho; ADSK finance.yaho; PODD finance.yaho; STZ finance.yaho; EIX finance.yaho. A later quote can be below the minimum of an earlier completed-bar window; the quote and bars have different cutoffs.

Publication calculations, not a revised decision: holding each scenario's economic terminal dollars, odds, authored stop, expected stop exit and T1 fixed, and mechanically rebasing the same SPY terminal scenarios to its 11:13 quote, leaves BRO net +0.3500%, ZTS +0.9761% and ADSK +1.2395%. The comparable SPY mean becomes −0.0527%; adjusted excess is approximately −0.8973 / −1.1712 / −1.7078 percentage points, respectively. BRO remains first. PODD, STZ and EIX remain nonpositive. The selected and alternative quotes are one minute apart, not synchronized executable stock/benchmark fills.

The fresh BRO bars leave $66.15 unbroken within the returned window and the quote above $65.75. ZTS remains above its $75.90 authored stop despite slipping below phase VWAP; ADSK remains above $232; PODD/STZ/EIX returned lows remain above their retained current-base levels $146.62/$129.45/$57.91. These are scoped support observations, not universal continuous-feed certification. Their historical broken holds remain broken. finance.yahoofinance.yahofinance.yahofinance.yahofinance.yahofinance.yaho

Risks And Thesis Breakers

Recovery fails at support. A subsequent print below the preidentified $66.15 support undermines the support-area premise and requires a fresh decision assessment. Below $65.97, the decider's $0.18 cash-equivalent support reference also fails. These are thesis diagnostics, not new instantaneous sell instructions. The publication completed-bar low was $66.255, so remaining support headroom is limited. finance.yahoo
Operating weakness is more durable than expected. Another deterioration in organic growth, margins or cash conversion would contradict the modest-recovery premise. The existing 1.2% organic growth and 200-basis-point adjusted-margin decline are already serious counterevidence. Acquisition integration, leverage and adjusted-EPS addbacks can obscure underlying progress. brownandbrown
The apparent upside is not readily realizable. The observed sequence includes $66.82/$66.89 obstacles and substantial prior supply before the $70.50 T1. A $73.7280 research profit barrier requires further continuation beyond T1. The model can lose money even when T1 is touched; the actual exit definition matters. Nearby highs and prior trading levels are historical observations, not promised resistance or floors. finance.yahoo
Delayed stops and gaps can dominate nominal risk. The authored stop is only 1.075749% below research entry, but the conditional expected stop exit is roughly 2.505072% lower before friction. Actual losses may exceed either estimate, including through overnight gaps, prolonged confirmation or unavailable liquidity. The 15% hard-loss condition is not a guaranteed maximum loss.
Calendar coverage is scoped. A fresh October 28 BRO issuer-page check still showed the completed October 27 call and October 26 latest results; no pending company-specific binary before the next regular execution window was identified. This is not exhaustive legal/regulatory clearance. investor.bbro
Alternative event limitations remain visible. Fresh issuer pages reconfirmed ZTS's November 5 results date and PODD's November 4 results date; the inherited exact times are 08:30 ET and premarket/08:00 ET call, respectively. ZTS is outside research maturity, while PODD is inside it. STZ's refreshed overview showed October 6 results and the completed October 7 call, not a certified full future calendar. ADSK's refreshed page exposed no usable event content; its next earnings date remains independently uncertified. EIX retains October 29 after-close earnings and unresolved current trial timing; its refreshed overview did not resolve those gaps. These limitations are not silently converted into clearance. investor.zoeinvestor.zoeinvestors.ininvestors.inir.cbrandsinvestors.aunewsroom.edisec.govedison
Macro, concentration and model risk. Rates/inflation shocks can overwhelm stock-specific recovery; a financial-services slot adds exposure alongside NDAQ. Neither a fitted exit-frequency reference class nor a reliable estimate-revision/social panel supports numerical precision. The 1.30-point uncertainty allowance exceeds estimated base excess; a small change in odds can erase the positive mean. This is why confidence is Low, not because confidence itself is an eligibility test.

Investment Recommendation

BUY NOW, one standard 1/12 slot in BRO, classified Speculative with Low confidence. This preserves the repaired authoritative decision rather than the superseded ZTS selection. The recommendation is for the current support-area setup, not conditional on waiting for a VWAP reclaim or a lower entry. It is justified by the decider's supported positive absolute net forecast and first-place adjusted-excess comparison—not by a claim that uncertainty-adjusted return is positive.

Use the exact policy authored_stop_ma60_confirm120_hard15_confirm10_tp1p8_v1:

The trailing 60-minute average must stay below the $65.75 authored stop for 120 minutes to confirm that stop condition. A single print below the threshold does not automatically execute it.
The 15% hard-loss condition requires 10 minutes of confirmation. At the original research entry, its arithmetic threshold is about $56.49525; the actual runtime threshold is entry-relative. Neither mechanism promises a threshold fill or caps gap loss.
The decider's $64.80 expected actual stop exit allows $0.95 of additional deterioration below the authored stop for confirmation delays/gaps. It is a conditional mean before execution friction, not a floor or a broker stop order guarantee.
T1 is $70.50. The full-position profit barrier is 1.8 times T1's percentage return, approximately $73.7280 at the research entry. There are no discretionary trims or replacement trailing stops in this forecast.
Apply 0.1% adverse exit slippage once, included in the selected model's 0.10-percentage-point friction. No separate commissions, taxes or financing charges are modeled; any additional real costs reduce the already small edge.
Exit at the seven-calendar-day maturity if neither earlier policy exit occurs, using the first liquid executable window at or after maturity. The research anchor is November 4, 2026, 11:03 EST, during the regular session; it preserves the same New York local time across DST, or 169 elapsed hours. Actual entry and maturity timestamps remain unobserved until runtime persistence, so the research timestamp is not an asserted broker fill. The checked exchange schedule supports the regular-session convention. aa.usno.navynyse
After an early exit, retain proceeds in cash through the scheduled horizon, with no extra interest assumed in these comparisons. Do not restart or extend the holding period to seek T1.

At one slot, the decider's +0.3176% stock mean contributes only about +0.0265% of total fund value before any effect from other holdings—a static-weight calculation, not a portfolio forecast. The financial-sector concentration and fragile mean argue against treating this as a high-conviction allocation.

No trade has been placed or fill observed. The separate VOO-versus-Gold-cash allocation branch is not applicable because the authoritative decision is a stock BUY, not certified stock N/A. Material price/support/news drift that changes eligibility or the comparison requires upstream decision repair, not a silent replacement, a longer horizon or automatic cash allocation.